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TOR complex 1 (TORC1) is a potent anabolic
regulator of cellular growth and metabolism. When
cells have sufficient amino acids, TORC1 is active
due to its lysosomal localization mediated via the
Rag GTPases. Upon amino acid removal, the Rag
GTPases release TORC1, causing it to become
cytoplasmic and inactive. We show here that, upon
amino acid removal, the Rag GTPases also recruit
TSC2 to the lysosome, where it can act on Rheb.
Only when both the Rag GTPases and Rheb are in-
active is TORC1 fully released from the lysosome.
Upon amino acid withdrawal, cells lacking TSC2 fail
to completely release TORC1 from the lysosome,
fail to completely inactivate TORC1, and fail to adjust
physiologically to amino acid starvation. These data
suggest that regulation of TSC2 subcellular locali-
zation may be a general mechanism to control its
activity and place TSC2 in the amino-acid-sensing
pathway to TORC1.INTRODUCTION
Small GTPases act asmolecular switches that alternate between
GTP-bound and GDP-bound states, thereby regulating a vast
array of cellular parameters, including mitochondrial activity,
cell growth, cell metabolism, and cell morphology. Small
GTPases are activated or inactivated by guanine nucleotide
exchange factors (GEFs) and GTPase-activating proteins
(GAPs), respectively, which regulate the GDP/GTP load of the
GTPase. Hence, understanding how GEFs and GAPs are regu-
lated is an important aspect of understanding GTPase function.
Compared to the regulation of GEFs, relatively little is known
about how the activity of GAPs is regulated (Cherfils and Ze-
ghouf, 2013). GAPs acting on members of the Rho and Arf
GTPase superfamilies are activated via membrane recruitment,
causing rearrangements in the structure of the GAPs uponmem-
brane binding (Cherfils and Zeghouf, 2013). Regulation of GAPs
acting on members of the Ras superfamily of GTPases is less
well understood. One such GAP is composed of the TSC1/
TSC2/TBC1D7 trimeric tumor suppressor complex (Dibble786 Cell 156, 786–799, February 13, 2014 ª2014 Elsevier Inc.et al., 2012), which acts on the small GTPase Rheb. Although it
is known that activity of this complex is regulated by phosphor-
ylation on multiple sites, it is not yet clear how these phosphor-
ylations affect TSC1/2 activity at the molecular level.
The kinase TOR complex 1 (TORC1) is a potent anabolic
regulator of cellular growth and metabolism that is often hyper-
activated in human cancers (Guertin and Sabatini, 2007;
Heitman et al., 1991; Huang and Manning, 2008; Laplante and
Sabatini, 2012; Proud, 2011). To be active, TORC1 needs to
bind a molecule of Rheb in the active, GTP-bound state (Inoki
et al., 2003; Tee et al., 2003). By inactivating Rheb, the TSC1/2
complex is therefore a critical upstream inhibitor of TORC1.
The TSC1/2 complex acts as a central point of integration of
almost all known inputs regulating TORC1, including cellular
stresses such as low oxygen or low ATP, and various growth-
promoting signals, such as PI3K, Ras, TNF, and Wnt signaling
(reviewed in Huang and Manning, 2008). The importance of the
tuberous sclerosis complex (TSC) on TORC1 signaling and
growth is highlighted by the fact that TSC2-inactivating muta-
tions have been found in various human growth-related diseases
(Huang and Manning, 2008). One other important input regu-
lating TORC1 activity is the availability of amino acids (Blom-
maart et al., 1995; Efeyan et al., 2012; Hara et al., 1998; Jewell
et al., 2013). Whether TSC2 is also involved in regulating
TORC1 in response to amino acids, however, is unclear because
various studies have come to differing conclusions (Gao et al.,
2002; Roccio et al., 2006; Smith et al., 2005).
Unlike all the other inputs that regulate TORC1 via TSC1/2 and
Rheb, amino acids regulate TORC1 via a separate set of small
GTPases, the Rag GTPases (Kim et al., 2008; Sancak et al.,
2008). The RagGTPases form heterodimeric complexes consist-
ing of RagA or RagB bound to RagC or RagD. These complexes
are stably anchored to lysosomal membranes via the LAMTOR/
Ragulator complex (Sancak et al., 2010). In the presence of
amino acids, the Rag dimers are in an ‘‘active’’ conformation
with RagA or RagB bound to GTP and RagC or RagD bound to
GDP. The active Rag dimers recruit TORC1 to the lysosomal
surface, where it binds Rheb to form an active holoenzyme. In
the absence of amino acids, the Rag GAP complex termed
GATOR1 causes the Rag dimers to switch into an inactive
conformation containing GDP-bound RagA/B, thereby releasing
TORC1 from the lysosomal surface (Bar-Peled et al., 2013;
Panchaud et al., 2013). This causes TORC1 to become inactive,
presumably because it no longer binds active Rheb on the
lysosomal surface. Hence, TORC1 activation can currently be
viewed as consisting of two aspects—the activation of Rheb in
response to a plethora of regulatory inputs and the localization
of TORC1 to lysosomal membranes in response to amino acids,
which allows it to meet Rheb.
In this study, we uncover subcellular localization as a mecha-
nism regulating activity of the TSC1/2 GAP complex. We find
that, upon amino acid removal, TSC1/2 is recruited to lysosomes
via binding to the Rag proteins, thereby bringing TSC1/2 in close
proximity to its target, Rheb. This suggests that relocalization of
GAPs to the vicinity of their substrates is onemechanism for their
regulation. Unexpectedly, we find that regulation of Rheb by
TSC1/2 upon amino acid starvation is required for TORC1 to
be released from lysosomal membranes. This suggests a ‘‘dual
anchoring’’ mechanism of TORC1 at the lysosome, perhaps
with the Rag proteins playing a crucial role in recruiting TORC1
to the lysosomal membrane and Rheb helping to retain it there.
We find that cells lacking TSC2 are impaired in their response
to amino acid starvation, failing to efficiently turn off TORC1.
As a result, cells lacking TSC2 are very sensitive to amino acid
starvation and die under conditions that control cells can cope
with. In sum, our data indicate that the TSC1/2 complex is
responsive to amino acid starvation and participates in amino
acid signaling to TORC1. Hence, the TSC1/2 complex appears
to play a role in regulating TORC1 in response to all regulatory
inputs known to date.
RESULTS
Rag GTPases Bind TSC2
While studying regulation of TORC1 by the Rag GTPases, we
noticed that Drosophila cells with reduced Rag protein levels
are unable to completely shut off TORC1 in the absence of amino
acids. When treated with medium lacking amino acids, control
S2 cells shut off TORC1 activity, assayed via S6 kinase (S6K)
phosphorylation, to roughly 7% the level of fully fed cells (Fig-
ure 1A). In contrast, S2 cells with RagA or RagC knockdown
are significantly impaired in their response to amino acid
removal, retaining circa 50% the TORC1 activity levels of fully
fed cells (Figure 1A). In this and all subsequent experiments,
amino acid removal is performed in the presence of dialyzed
serum, thereby specifically removing amino acids, but not
growth factors, from cell culture media. Furthermore, immuno-
blot quantifications are performed on a LI-COR imaging system,
providing a means to quantitatively study TORC1 activity (see
Experimental Procedures). This phenotype was reiterated with
independent dsRNAs targeting nonoverlapping regions of
RagA and RagC (Figure S1A available online), proving specificity
of the phenotype. Furthermore, knockdown of LAMTOR3 also
led to similar, impaired TORC1 inactivation upon amino acid
withdrawal (data not shown). Similar effects can also be
observed in human HEK293FT cells (Figure S1C) and in previous
reports (see Figure 3H in Sancak et al., 2008). As previously
shown (Kim et al., 2008; Sancak et al., 2008), S2 cells and
HEK293FT cells with Rag protein knockdown also show severely
compromised reactivation of TORC1 upon amino acid readdition
(Figures S1B and S1D). Together, these data indicate that the
Rag GTPases not only activate TORC1 in the presence of aminoacids but also actively repress TORC1 in the absence of amino
acids. Since the Rag proteins ‘‘let go’’ of TORC1 in the absence
of amino acids (Sancak et al., 2008), it is not easy to explain how
they could also be actively repressing TORC1. Thus, the Rag
GTPases appear to have an additional activity besides their
ability to reversibly bind TORC1.
We hypothesized that the Rag proteins might be recruiting
inhibitory factors to the lysosome upon amino acid starvation.
To investigate this, we immunoprecipitated FLAG-RagA and
FLAG-RagC from Drosophila S2 cells and performed shotgun
mass spectrometry analysis to identify interacting partners.
Among the identified proteins, as expected, were known com-
ponents of the Ragulator complex (Sancak et al., 2010) such
as p14, p18, and MP1, as well as TOR and Raptor (Figure 1B).
This analysis also found significant amounts of Tsc2 as a Rag-
binding protein (Figure 1B). One possibility could be that binding
of Tsc2 to the Rag GTPases is indirect due to the Rag GTPases
binding TORC1, which binds Rheb, which binds Tsc2. However,
as shown below, binding between Tsc2 and the Rag GTPases
increases when the Rag GTPases are in the inactive state and,
hence, bind less TORC1, arguing against this possible explana-
tion. Because Tsc2 is a negative component of the TOR signaling
pathway, we decided to study this interaction in more detail.
We first aimed to confirm the interaction between Tsc2 and
the Rag GTPases by coimmunoprecipitation (coIP). Indeed,
FLAG-tagged Drosophila RagA and RagC were able to coIP
epitope-tagged Tsc2, but not an unrelated protein, Medea (Fig-
ure 1C). Likewise, epitope-tagged human TSC2was able to coIP
human Rag GTPases in HEK293FT cells (Figure 1D). As dis-
cussed below, a complex consisting of human RagA and RagC
can also coIP endogenous TSC2 (Figure 2E). In sum, the inter-
action between the Rag GTPases and TSC2 appears to be spe-
cific and evolutionarily conserved from flies to humans.
Delineation of Interacting Regions of TSC2 and the Rag
Proteins
We next aimed to characterize in more detail the binding
between TSC1/2 and the Rag complex. We first asked which
component of the Rag complex is binding TSC1/2. Immuno-
precipitation of tagged TSC2 showed that it binds RagA signifi-
cantly more strongly than the other Rag proteins (Figure 1D),
suggesting that RagA is a likely binding partner for the TSC1/2
complex. To study the residues in RagA involved in TSC2 bind-
ing, we exploited the fact that RagA has significantly stronger
binding to TSC2 compared to RagB despite the two proteins
being almost identical. Compared to RagB, RagA is lacking an
N-terminal extension of 33 amino acids and has 5 amino acid
substitutions at the C terminus of the protein (Figure 2A). We
asked which of these differences is important for RagA binding
to TSC2. Either removal of the N-terminal extension of RagB
or introduction of the five C-terminal amino acid changes into
RagB caused improved binding to TSC2 (Figures 2A and 2B),
indicating that both the N-terminal and the C-terminal residues
affect TSC2 binding. We then introduced the five RagA-specific
amino acid substitutions individually into RagB and found that
each of them improves the binding of RagB to TSC2 (Figures
2A and 2C). Hence, each of these five amino acids of RagA
contributes toward TSC2 binding, and, indeed, these five aminoCell 156, 786–799, February 13, 2014 ª2014 Elsevier Inc. 787
Figure 1. Conserved Binding of TSC2 to the Rag GTPase Complex
(A) Drosophila Rag proteins are required for complete TORC1 inactivation upon amino acid withdrawal. Immunoblots of S2 cells treated with dsRNAs against
LacZ (control), RagA, or RagC incubated with media lacking only amino acids in the presence of dialyzed serum for the indicated times.
(B) Shotgun mass spectrometry analysis identifies Tsc2 as a Rag-binding protein. Two statistics of peptide abundance are shown for Tsc2 and control proteins
from two independent FLAG-RagA + FLAG-RagC immunoprecipitates (IP) from S2 cells.
(C) Confirmation by coIP that Rag proteins bind Tsc2, but not an unrelated protein, Medea. Immunoblots of anti-FLAG IPs from Drosophila S2 cells expressing
FLAG-tagged RagA + RagC and V5-tagged Tsc2 or Medea, as indicated.
(D) Human TSC2 binds human Rag dimeric complexes. Immunoblots of anti-FLAG IPs fromHEK293FT cells expressing FLAG-tagged TSC2 andHA-GST-tagged
Rag proteins or an HA-GST control, as indicated.acid differences between RagA and RagB are evolutionarily
conserved.
To identify the binding partner in the TSC1/2 complex, we
coIPed epitope-tagged TSC1 or TSC2 individually with RagA+C,
revealing that TSC2, but not TSC1, binds the Rag complex (Fig-
ure S2A). To study which residues in TSC2 are responsible for
Rag binding, we generated a series of C-terminal truncations
of TSC2 and tested them by coIP (Figure S2B). This analysis
revealed that the N-terminal 424 amino acids of TSC2 bind
very strongly the Rag proteins but that, nonetheless, the remain-
ing amino acids 425–1,784 also have Rag binding capacity (Fig-
ure 2D). In sum, binding between the two complexes appears to
be mediated via TSC2 binding to RagA. Although the interaction788 Cell 156, 786–799, February 13, 2014 ª2014 Elsevier Inc.surfaces are complex, binding depends strongly on five individ-
ual amino acids in RagA identified in this analysis.
Binding betweenRag Proteins and TSC2 Increases upon
Amino Acid Removal
We asked whether binding between the Rag proteins and TSC2
depends on cellular amino acid signaling because our initial
findings suggested that the Rag complex might be recruiting a
TOR inhibitor upon amino acid removal. Indeed, a complex
consisting of human RagA and RagC (‘‘RagA+C’’) was able to
coIP endogenous TSC2 (lanes 1 and 2, Figure 2E), and this inter-
action became stronger upon amino acid removal (lanes 2
versus 4, Figure 2E). One mechanistic explanation could be
(legend on next page)
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that binding between TSC2 and the Rag GTPases depends on
the state of activation of the Rag proteins, which switch to the
‘‘inactive’’ RagAlow-nucleotide/RagCGTP conformation upon amino
acid removal. To test this, we assayed binding between endog-
enous TSC2 and mutant variants of the RagA/RagC complex,
locked into either the active (RagAGTP/RagClow-nucleotide) or in-
active (RagAlow-nucleotide/RagCGTP) states (Sancak et al., 2008),
and found that, indeed, TSC2 binds the Rag proteins much
more strongly when they are in the inactive state (Figure 2F).
Binding of endogenous TSC1 to the Rag proteins closely paral-
leled binding of TSC2 (Figure 2F), indicating that TSC2 is
mediating binding of the entire TSC1/2 complex because
TSC1 cannot bind the Rag proteins by itself (Figure S2A). As
expected (Sancak et al., 2008), Raptor binding was strongest
when the Rag proteins were in the active state (Figure 2F),
therefore anticorrelating with TSC2 binding. As a negative
control, endogenous PTEN did not show any binding to the
Rag proteins (Figure 2F). This preference for binding the inactive
Rag complex cannot be ascribed to the state of activation of
any one of the two Rags but rather appears to depend on the
conformation of both RagA and RagC because states of inter-
mediate activation (RagAGTP/RagCGTP or RagAlow-nucleotide/
RagClow-nucleotide) also showed intermediate levels of TSC2
binding (Figure S2C). In sum, binding of TSC2 to the Rag com-
plex appears to anticorrelate with binding of mTORC1 to the
Rag complex, with mTORC1 binding predominantly when the
Rag complex is active in the presence of amino acids and
TSC2 binding predominantly when the Rag complex is inactive
in the absence of amino acids.
TSC2 Is Recruited to the Lysosome in a Rag-Dependent
Manner upon Amino Acid Removal
Preferential binding of TSC2 for the inactive Rag complex, which
is localized on the lysosome, raised the possibility that TSC2
might be recruited to lysosomes upon amino acid removal. Using
an antibody that specifically recognizes endogenous TSC2
(Dibble et al., 2012 and Figure S3A), we found that, in the pres-
ence of amino acids, TSC2 is diffusely cytoplasmic in HEK293FT
cells in a pattern that is not concentrated on lysosomes/late en-
dosomes (marked by LAMP2, henceforward referred to as ‘‘lyso-
somes’’) relative to elsewhere in the cytoplasm (+aa, Figure 3A).
Upon removal of amino acids, however, TSC2 quickly accumu-
lates on lysosomes (15 min aa, Figure 3A) and remains associ-
ated with lysosomes for hours (240 min aa, Figure 3A). UponFigure 2. TSC2 Binding to the Rag Proteins Depends on Cellular Amin
(A) Schematic diagram of RagA, RagB, and various mutants used in (B)–(D) to de
(B) Both N-terminal and C-terminal regions of RagA are involved in TSC2 binding.
as depicted in (A), showing that both the N-terminal 33 amino acids, as well as t
(C) All five C-terminal amino acids specific for RagA, as shown in (A), contribute to
introduced singly. CoIP experiments were performed as in (B). In (B) and (C), HA
(D) The N-terminal 424 amino acids of TSC2 bind strongly to Rag proteins, althou
CoIP in HEK293FT cells of truncated versions of FLAG-TSC2 with HA-tagged Rag
complex binds TSC2 most strongly, as in (F).
(E) Amino acid starvation increases binding of endogenous TSC2 to the Rag
FLAG-tagged RagA + RagC, treated with medium containing or lacking amino a
(F) Endogenous TSC2 and TSC1 bind most strongly to Rag dimers in the inactive
HEK293FT cells expressing FLAG-taggedWT RagA + RagC andmutants locked i
states.
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cytoplasmic again (Figure 3B). Similar relocalization of TSC2
to lysosomes could also be observed in mouse embryonic
fibroblasts (MEFs) (Figure 3C), and it was confirmed at the ultra-
structural level by anti-TSC2 immunoelectron microscopy (Fig-
ure S3B). Furthermore, TSC1 also relocalizes to lysosomes
upon amino acid removal, suggesting that the whole TSC1/2
complex relocalizes (Figure S3C).
In agreement with the biochemical data presented above,
lysosomal accumulation of TSC2 upon amino acid withdrawal
is mediated via the Rag proteins because it is strongly blunted
upon amino acid starvation in MEFs lacking p14/LAMTOR2 in
which the Rag proteins are not lysosomally localized (Sancak
et al., 2010) (Figures 4A and 4A0), in MEFs or HEK293FT cells
transiently lacking expression of LAMTOR components due to
siRNA-mediated knockdown (data not shown), or in MEFs in
which the Rag proteins have been knocked down (Figure 4B).
As expected (Sancak et al., 2008), Rag knockdown caused
reduced TORC1 activation upon amino acid readdition (Fig-
ure S4A), as well as reduced TOR lysosomal localization (Fig-
ure S4B), confirming successful knockdown of the Rag proteins.
In agreement with the biochemical data showing preferential
binding of TSC2 for the inactive Rag complex, recruitment of
TSC2 to lysosomes in the absence of amino acids was also abro-
gated upon knockdown of the Rag GAP GATOR1 complex com-
ponents DEPDC5, NPRL2, and NPRL3 (Figures 4C and S4E). In
this setup, the Rag complex is present on lysosomes but remains
in the activated state (Bar-Peled et al., 2013; Panchaud et al.,
2013), leading, as previously shown, to increased TORC1 activity
and lysosomal localization in the absence of amino acids (Fig-
ures S4C and S4D). These data suggest that recruitment of
TSC2 to the lysosome upon amino acid withdrawal is due to
the Rag proteins changing to the inactive conformation.
TSC2 Is Required for Complete Inactivation of TORC1
upon Amino Acid Removal
Having seen that TSC2 is recruited to lysosomes upon amino
acid removal, we asked whether this has a functional con-
sequence in terms of TORC1 activity. We tested whether cells
lacking TSC2 are impaired in their ability to turn off TORC1
upon amino acid removal. Unlike control Drosophila S2 cells,
which shut off TORC1 almost completely upon amino acid
starvation, S2 cells with decreased Tsc2 levels show only a par-
tial, initial drop in TORC1 activity, after which they retain ao Acid Signaling
lineate the binding interfaces between TSC2 and RagA.
CoIP of FLAG-TSC2 with RagA, RagB, and hybrid versions of the two proteins
he 5 C-terminal amino acids specific for RagA, impact TSC2 binding.
ward TSC2 binding, as each one improves the binding of RagB to TSC2 when
-GST-RagC was coexpressed with the RagA/B variants.
gh the remaining amino acids 425–1,784 also contribute toward Rag binding.
A and RagC. Inactive-locked RagAlow-nucleotide and RagCGTP were used, as this
GTPases. Immunoblots of anti-FLAG IPs from HEK293FT cells expressing
cids in the presence of dialyzed FBS for 1 hr.
state, which antiparallels Raptor binding. Immunoblots of anti-FLAG IPs from
nto the active RagAGTP/RagClow-nucleotide or inactive RagAlow-nucleotide/RagCGTP
Figure 3. Amino Acid Starvation Causes TSC2 Lysosomal Localization in a Rag-Dependent Manner
(A and C) TSC2 accumulates on lysosomes upon amino acid deprivation. Confocal micrograph of HEK293FT cells (A) or MEFs (C) treated with medium containing
or lacking all amino acids in the presence of dialyzed FBS for the indicated times, stained for TSC2 (green) and the lysosomal marker LAMP2 (red). LAMP2
aggregates do not show TSC2 accumulation in the +aa condition.
(B) TSC2 quickly relocalizes away from lysosomes upon amino acid readdition. HEK293FT cells were starved for amino acids in the presence of dialyzed serum
for 4 hr and then resupplied with amino-acid-containing media for 5 min. Cells were stained and imaged as in (A).significantly elevated amount of TORC1 activity stably for up to
2 hr (Figure 5A). This cannot be explained simply by elevated
starting levels of TORC1 activity in the Tsc2 knockdown cells
because S2 cells lacking PTEN have similarly elevated starting
levels of TORC1 activity but nonetheless efficiently shut off
TORC1 upon amino acid removal (Figure 5B). These data are
in agreement with previous observations (Gao et al., 2002). As
in Drosophila cells, MEFs lacking TSC2 or TSC1 are also unable
to completely inactivate mTORC1 upon amino acid starvation
(Figures 5C and S5A). Also, in mouse cells, this cannot be
explained by elevated starting levels of mTORC1 activity
because PTEN knockout MEFs also start with elevatedmTORC1
activity but efficiently shut off mTORC1 upon amino acid with-
drawal (Figure 5D). Treatment of TSC1/ or TSC2/ MEFs
with the TORC1-specific inhibitor rapamycin eliminated theaberrantly elevated S6K phosphorylation, showing that it is
reflecting elevated activity of TORC1 and not another kinase
(Figures 5C and S5A). An alternate explanation could be that
lack of the TSC1/2 complex leads to reduced phosphatase activ-
ity toward S6K. To test this, we performed a rapamycin treat-
ment time course to compare the rate of S6K dephosphorylation
in control and TSC2 knockdown conditions. In both MEFs and
Drosophila S2 cells, however, rapamycin treatment caused rapid
dephosphorylation of S6K with similar kinetics in cells containing
or lacking TSC2 (Figures S5F and S5G, see quantification), indi-
cating that phosphatase activity is unchanged. We wondered
whether cells lacking TSC2 might simply have a delayed
response to amino acid starvation, in which case extending the
time of incubation in medium lacking amino acids would allow
them to more completely shut off mTORC1. Astoundingly,Cell 156, 786–799, February 13, 2014 ª2014 Elsevier Inc. 791
Figure 4. Lysosomal Recruitment of TSC2 Depends on the Rag Proteins
(A and A0) Lysosomal localization of TSC2 upon amino acid removal requires the LAMTORcomplex. Confocal micrograph of p14/LAMTOR2 knockout MEFs (A) or
control p14 knockout MEFs reconstituted to express an EGFP-p14 fusion (A0), treated with medium containing or lacking amino acids for 1 hr in the presence of
dialyzed FBS. Lysosomes were marked either with anti-LAMP2 antibody or with the lysosomally localized EGFP-p14.
(legend continued on next page)
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however, TSC2/ MEFs retained elevated levels of mTORC1
activity in the absence of amino acids for up to 1.5 to 2 days,
at which point they started dying, leading to concomitant drops
in both phospho-S6K and total S6K signals on the immunoblots
(Figure S5B). When phospho-S6K signals are normalized to total
S6K levels, one can see that TSC2/ MEFs retain a consistent
level of mTORC1 activity up to their death (Figure S5B, bottom).
In sum, TSC2 seems to be intimately linked to amino acid
sensing by cells, in that (1) TSC2 localization changes upon
amino acid removal, and (2) TSC2 is required for mTORC1 to fully
turn off in the absence of amino acids.
TSC2 Is Required to Completely Release mTORC1 from
the Lysosome upon Amino Acid Starvation
mTORC1 activation requires two regulated steps—one is activa-
tion of Rheb, and the other is localization of mTORC1 to the lyso-
somal surface where it meets Rheb, thereby forming an active
complex (Inoki et al., 2003; Tee et al., 2003). In particular, the
presence or absence of amino acids is known to regulate
mTORC1 localization (Kim et al., 2008; Sancak et al., 2008).
Since TSC2 appears to be involved in amino acid signaling to
mTORC1, we asked whether TSC2 is required for the proper
subcellular localization of mTORC1. As previously described
(Kim et al., 2008; Sancak et al., 2008), in control cells, mTOR
accumulates on lysosomes in the presence of amino acids and
becomes diffusely cytoplasmic in the absence of amino acids
(Figure 6A). In contrast, in TSC2 null MEFs (which, as expected,
are larger than control cells), mTOR localization is very strongly
lysosomal, both in the presence and in the absence of amino
acids (Figures 6A0 and 6B, top). This defect can be rescued by
transfecting them with a TSC2 expression plasmid, confirming
specificity of the phenotype (Figure 6B, bottom, note lysosomally
localized mTOR in the starved nontransfected TSC2/ cells,
which is rescued in the cells expressing TSC2 + EGFP). As
expected from the known effect of TSC1 loss on TSC2 stability,
this defect in mTOR localization could also be observed in TSC1
null MEFs (Figure S6A). Therefore, unexpectedly, the TSC1/2
complex is required for mTORC1 to be released completely
from lysosomes upon amino acid withdrawal. Consistent with
this phenotype being specific for loss of the TSC1/2 complex,
and in agreement with the data presented in Figure 5, mTOR
was readily released upon amino acid removal from lysosomes
in PTEN mutant MEFs, which also start with elevated mTORC1
activation levels (Figure S6B).
Since mTORC1 localization is known to be regulated via the
GTP/GDP load of the Rag GTPases (Sancak et al., 2008) and
TSC2 has been described as a GAP for other small GTPases
(Inoki et al., 2003; Wienecke et al., 1995; Xiao et al., 1997), we
hypothesized TSC2 might regulate mTORC1 localization by
acting as a Rag GAP. However, we radioactively quantified the
relative GTP/GDP load of overexpressed Rag proteins in cells(B) Lysosomal localization of TSC2 upon amino acid removal requires the Rag pro
targeting the various Rag proteins, treated with medium containing or lacking amin
as in (A).
(C) Lysosomal localization of TSC2 upon amino acid removal requires that the Ra
siRNA or siRNAs targeting components of the GATOR1 complex DEPDC5, NPRL
removal. Cells were stained and imaged as in (A).in the presence or absence of coexpressed TSC2 and could
find no evidence to support this (data not shown). Another
possible explanation could be that TSC2 affects the level of
intracellular amino acids, thereby affecting mTORC1 locali-
zation. However, this does not seem to be the case: the intracel-
lular levels of ten amino acids drop upon amino acid starvation.
For these, the intracellular levels drop equivalently, or even more
dramatically, in the TSC2 null MEFs compared to control cells
(Figure S5C). Unexpectedly, the intracellular levels of eight other
amino acids either remain constant or increase in control cells
upon amino acid removal from the medium (Figures S5D and
S5E). For these, the intracellular levels either increase less
dramatically or actually decrease in TSC2 null MEFs compared
to controls (Figures S5D and S5E). Because TSC2 acts via
Rheb (Inoki et al., 2003) and because Rheb is known to bind
themTORC1 complex (Long et al., 2005), this raised the possibil-
ity that Rheb might mediate the effect of TSC2 on mTOR locali-
zation by helping to anchor mTOR at the lysosomal membrane in
collaboration with the Rag proteins. Indeed, in TSC2 null MEFs,
knockdown of Rheb by siRNA allowed mTOR to be released
from lysosomes upon amino acid removal (Figure 6C, controls
in Figures S6C and S6D). Equivalent results could be observed
in TSC2 null cells stably transfected with inducible shRNA con-
structs targeting an independent region of Rheb, confirming
specificity of the effect (Figure S6E). Furthermore, overexpres-
sion of active, but not inactive, Rheb was sufficient to localize
mTOR to the lysosome even in the absence of amino acids
(data not shown). In sum, these results identify Rheb as the
mTORC1-anchoring activity in the TSC2 null MEFs.
TSC2 Is Required for Cells to Respond Physiologically to
Amino Acid Starvation
The data presented above support a model (detailed below and
in Figure S7C) whereby TSC2 is required for cells to respond
correctly to the removal of amino acids, allowing mTORC1 to
be fully displaced from the lysosomal surface, thereby allowing
it to become fully inactivated. We asked whether the inability of
TSC2 null cells to respond correctly to amino acid starvation at
the molecular level is paralleled by an equivalent defect at the
physiological level. One might expect that, if cells do not fully
shut off mTORC1 upon amino acid starvation, this may lead to
a metabolic catastrophe, as the demand for nutrients by cellular
processes is not correctly reduced to match the reduced supply.
To this end, we deprived control and TSC2 null MEFs of amino
acids in the presence of dialyzed serum. Surprisingly, control
MEFs were able to survive these conditions for several days;
the cells were still visibly present after the treatment, and they
recommenced proliferating when given complete medium
(Figure 7A), suggesting that they were in a quiescent state.
This could also be quantified using a standard viability assay
that quantifies ATP levels (blue trace, Figure 7B). In contrastteins. MEFs transfected with control siRNA against Renilla luciferase or siRNAs
o acids for 1 hr in the presence of dialyzed FBS. Cells were stained and imaged
g proteins change to the inactive conformation. MEFs transfected with control
2, or NPRL3 required for the Rag proteins to become inactive upon amino acid
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(and in agreement with data in Figure S5B), TSC2 null MEFs
died within 3 days in response to amino acid removal, indicating
a physiologically defective response to amino acid starvation
(Figures 7A and 7B). If TSC2 null MEFs are dying upon amino
acid withdrawal due to an incomplete inhibition of mTORC1
activity, then blocking mTORC1 pharmacologically in these
cells should improve their survival. Indeed, treating TSC2 null
MEFs with rapamycin rescued their death upon amino acid
starvation (Figures 7D and 7E). One catabolic process that is
activated in response to low mTORC1 activity to promote cell
survival upon amino acid starvation is autophagy. Control
MEFs efficiently activated autophagy upon amino acid starvation
(seen as accumulation of a faster migrating form of LC3A and
degradation of p62, Figure 7C). In contrast, TSC2 null MEFs
were impaired in activating autophagy (Figure 7C), thereby iden-
tifying one of probably multiple mTORC1-dependent physiolog-
ical responses to amino acid starvation that are defective in
TSC2 null cells. In sum, these data support the notion that
TSC2 is required physiologically for cells to respond to amino
acid starvation.
DISCUSSION
The data presented here suggest a model whereby, in the pres-
ence of amino acids, mTORC1 accumulates on lysosomes due
to a dual anchoring activity composed primarily of the Rag
proteins but supported by Rheb (Figure S7C). While amino acids
are present, binding between the Rag proteins and TSC1/2 is
low, causing the TSC1/2 complex to remain cytoplasmic. Upon
amino acid removal, the Rag proteins cause mTORC1 to be
released from lysosomes via two independent activities, both
of which result from the Rag proteins shifting to an inactive
conformation. First, the Rag proteins reduce their binding for
mTORC1, thereby releasing one of the two activities tethering
mTORC1 at the lysosome. Second, the Rag proteins actively
recruit TSC2 to the lysosome. This allows TSC2 to act on
Rheb, thereby releasing the second tethering activity keeping
mTORC1 on the lysosome. In the absence of TSC2, this second
activity is unaffected, causing mTORC1 to remain lysosomally
localized (Figure S7C, right).
The LAMTOR complex (composed of the p18, p14, and MP1
proteins) has been shown to serve as a docking point for
mTORC1 (Sancak et al., 2010) and MEK/ERK complexes
(Schaeffer et al., 1998; Teis et al., 2002), regulating their recruit-
ment to late endosomes/lysosomes and their activation status.
Our data demonstrate that integrity of the LAMTOR complex is
critical for proper TSC2 subcellular localization upon amino
acid withdrawal, therefore highlighting the importance of this
scaffold complex for endomembrane-mediated activation/inac-
tivation of signaling pathways.Figure 5. TSC2 Loss Causes Insensitivity to Amino Acid Removal in D
(A andB) Tsc2, but not PTEN, knockdownmakesDrosophila cells largely insensitiv
dsRNA, dsRNA against GFP (control), or dsRNA against Tsc2, treated with m
knockdown S2 cells efficiently inactivate TORC1 upon amino acid removal, desp
(C and D) TSC2 knockout MEFs do not completely shut off TORC1 upon amin
TSC2/ and the respective control TSC2+/+ MEFs or (D) PTEN knock-out MEFs
Lanes 6 and 12 (C), cells treated with 20nM Rapamycin for 1 hr in the presenceThe data presented here show that the TSC1/2 complex is part
of the molecular machinery required for mTORC1 to respond
properly to the absence of amino acids. We find that the
TSC1/2 complex responds to amino acid starvation by changing
its subcellular localization (Figures 3, 4, S3B, and S4E) and that
TSC2 is required for mTORC1 to be fully released from lyso-
somes and fully inactivated upon amino acid removal (Figures
5 and 6). That said, however, in cells lacking TSC2, there is
nonetheless a clear initial drop in TORC1 activity upon amino
acid removal (Figures 5A and 5C). The remaining activity is
then sustained indefinitely (Figure S5B). Hence, mTORC1 ap-
pears to consist of two pools or two degrees of activation, one
of which requires TSC2 to become inactive upon amino acid
withdrawal and one of which responds independently of TSC2.
This might explain why previous studies arrived at differing inter-
pretations of their data (Gao et al., 2002; Roccio et al., 2006;
Smith et al., 2005) because there is some response of TORC1
to amino acid removal in TSC2 null cells; however, the response
is severely blunted compared to controls. Further work will
hopefully shed light on these two pools of activity. Although
the impairment in mTORC1 response to amino acids in TSC2
null cells is partial, it is nonetheless of critical physiological
relevance because TSC2 null MEFs die upon amino acid removal
in sharp contrast to control MEFs (Figures 7 and S5B).
Looking at the model in Figure S7C from several perspectives
yields various insights. (1) Regulation of mTORC1 activation
could previously be rationalized as consisting of two indepen-
dent, parallel steps: first, regulation of Rheb via TSC1/2 in
response to a plethora of signals including stresses and
growth factor signaling, and second, regulation of mTORC1
subcellular localization to lysosomal membranes in response to
amino acids. Only when mTORC1 is properly localized to meet
active Rheb would an active holoenzyme form. The data pre-
sented here blur the distinction between these two steps
because Rheb also affects mTORC1 localization, and amino
acids also signal through TSC1/2. Instead, the two sets of regu-
latory inputs into mTORC1 appear to be more integrated. (2)
Amino acid removal is ‘‘dominant’’ over growth factor signaling,
causing mTORC1 to shut off despite the presence of growth
factors (Blommaart et al., 1995; Hara et al., 1998). This was
previously explained by the fact that, in the absence of amino
acids, mTORC1 could not localize near active Rheb to form an
active complex. Our dual tethering model is also consistent
with this notion but for a slightly modified reason, which is that
amino acid starvation acts to sever both the Rag and Rheb
lysosomal tethering activities. (3) Seen from the perspective of
the Rag proteins, they swap binding partners depending on
the state of amino acid signaling, binding preferentially to
mTORC1 in the presence of amino acids, and binding preferen-
tially to the TSC1/2 complex in the absence of amino acids.rosophila and Mammalian Cells
e to amino acid removal. (A) Immunoblots ofDrosophila S2 cells treatedwith no
edia containing (+) or lacking amino acids for the indicated times. (B) PTEN
ite starting with elevated TORC1 activity levels.
o acid withdrawal, whereas PTEN knockout MEFs do. Immunoblots from (C)
treated with medium containing or lacking amino acids for the indicated times.
of amino acids (Rapa). Quantified with a LI-COR imaging system.
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Figure 6. TSC2 Is Required for mTOR to Localize away from Lyso-
somes upon Amino Acid Removal in a Rheb-Dependent Manner
(A and B) mTOR is released from lysosomes upon amino acid removal in
control (A), but not TSC2 null, MEFs (A0). This is rescued by re-expressing
796 Cell 156, 786–799, February 13, 2014 ª2014 Elsevier Inc.Consequently, mTORC1 and TSC1/2 also swap subcellular
localizations.
We noticed that, in our hands, knockdown of Rag proteins did
not result in as strong a reduction in TORC1 activity in the pres-
ence of amino acids as was previously reported (Kim et al.,
2008; Sancak et al., 2008). The simplest explanation is tech-
nical—that our Rag knockdowns are not strong enough to fully
abrogate Rag recruitment of mTORC1 in the presence of amino
acids but are sufficient to impair Rag recruitment of TSC2 in the
absence of amino acids. In that case, optimizing the Rag knock-
downs might lead to even stronger effects than the ones we
present here. Two alternate biological explanations, however,
might be worth investigating in the future. The first is that our
data suggest a dual anchoring mechanism of mTORC1 at the
lysosomal membrane—one by the Rag proteins and one by
Rheb. It is possible that the relative contribution of lysosomal
tethering of mTORC1 by the Rag proteins and by Rheb might
depend on their relative levels of expression and activation in
the system being studied. This balance will likely depend on
the cell line and on cell culture conditions. A second possible
explanation could be one of biological kinetics, influenced
by treatment strategy. The outcome might be quantitatively
different if one looks at acute amino acid removal from cells
adapted to complete medium (which we do here) or if one looks
at amino acid add-back to cells that have equilibrated their
signaling to the absence of amino acids. Indeed, we see that,
if we knock down the Rag proteins in HEK293FT cells, we do
not see a dramatic reduction in mTORC1 activity in the presence
of amino acids (Figure S1D, lanes 1–3). However, if we remove
amino acids for 1 hr and then readd amino acids for 30 min, the
same degree of Rag knockdown causes an obvious reduction
in mTORC1 activity (Figure S1D, lanes 7–9). Likewise, in
Drosophila S2 cells, RagC knockdown only had a mild effect
on TORC1 activity in untreated cells (Figures 1A and S1A) but
severely blunted the ability of cells to respond to amino acid
add-back (Figure S1B). This difference between amino acid
removal and amino acid add-back raises the interesting possi-
bility that the Rag proteins are key in recruiting mTORC1 to
the lysosome, a process that happens upon amino acid readdi-
tion, and that both the Rag proteins and Rheb work together to
keep mTORC1 on the lysosome once it is there. Indeed, in
agreement with this model, mTOR is able to be recruited to
the lysosome upon amino acid readdition in TSC2 null MEFs
in which Rheb is knocked down (Figures S7A and S7B), indi-
cating that, although Rheb tethers mTOR to the lysosome
upon amino acid removal (Figure 6C), it is not required for de
novo recruitment of mTOR to the lysosome upon amino acid
add-back.TSC2 + EGFP (to mark transfected cells), but not EGFP alone, in the TSC2 null
MEFs (B). Note that the cell expressing TSC2 and EGFP no longer has mTOR
accumulated on lysosomes, whereas the surrounding, nontransfected cells
retain lysosomally localized mTOR.
(C) Defective release of mTOR from lysosomes upon amino acid withdrawal
in TSC2 null MEFs is rescued by knocking down Rheb. TSC2 null MEFs
transfected with either Rheb siRNAs (top) or control siRNAs (bottom) treated
for 1 hr with medium containing or lacking amino acids in the presence of
dialyzed FBS.
Figure 7. TSC2 Null Cells Are Impaired in Their Response to Amino Acid Starvation, Leading to Their Death
(A and B) Amino acid removal causes cell death in TSC2 null cells. TSC2/ and the respective TSC2+/+ control MEFs were treated on day 1 with medium
containing or lacking amino acids in the presence of dialyzed FBS. On day 4, all samples were given fresh medium containing amino acids. (A) DIC images
captured on days 1, 4, and 7. (B) Cell viability was determined using the Cell-Titer Glo kit (Promega).
(C) TSC2 null MEFs show defective autophagy induction upon amino acid withdrawal. TSC2/ and the respective TSC2+/+ control MEFs were treated with
medium containing (+) or lacking amino acids in the presence of dialyzed FBS for the indicated times. Activation of autophagy visualized on an immunoblot via
increased conversion of LC3A to the faster migrating lipidated form II and degradation of p62 protein.
(D and E) Pharmacological inhibition of TORC1 rescues survival of TSC2 null MEFs upon amino acid withdrawal. TSC2/ mouse embryonic fibroblasts were
treated with medium containing (+aa) or lacking (aa) amino acids with or without 20 nM Rapamycin (-aa/+Rapa) for 3 days in the presence of dialyzed FBS. DIC
images (D) and respective cell viability titers were determined using the Cell-Titer Glo kit (Promega) (E).
Error bars represent SD.Previous reports showed that hyperactive mTORC1 signaling
or dysregulated translation can lead to a metabolic mismatch
in supply and demand, leading to cellular or organismal death(Choo et al., 2010; Efeyan et al., 2013; Kim et al., 2008; Leprivier
et al., 2013; Teleman et al., 2005). We hypothesized that, if TSC2
is required for mTORC1 activity to respond to amino acidCell 156, 786–799, February 13, 2014 ª2014 Elsevier Inc. 797
starvation, then TSC2 might also be necessary for cells to
respond physiologically to this stress. Indeed, TSC2 knockout
MEFs die upon removal of amino acids, whereas control cells
do not (Figure 7). The fact that cells with elevated mTORC1
activity due to impaired nutrient sensing die when deprived of
amino acids raises the interesting hypothesis that limiting
nutrient supply to tumors of certain genotypes might have a
beneficial effect on their treatment. Consistent with this effect
being due to elevated mTORC1 activity, the death of TSC2
knockout MEFs is rescued by rapamycin treatment (Figure 7).
This leads to the unexpected finding that rapamycin can actually
promote cell survival under nutrient deprivation conditions,
which might have therapeutic implications in mTOR-related
malignancies.
We identify here the subcellular localization of TSC1/2 as one
mechanism regulating this GAP holoenzyme. In an accompa-
nying manuscript in this issue of Cell, Menon et al. (2014) show
that TSC2 subcellular localization is also regulated by insulin
signaling. They show that, in the absence of FBS, TSC2 is lyso-
somally localized. We show here that, in the absence of amino
acids, TSC2 is lysosomally localized, even in the presence of
growth factor signaling (FBS). Hence, the presence of both
amino acids and growth factor signaling are required to keep
TSC2 in the cytoplasm, and as long as one of the two is missing,
TSC2 becomes lysosomally localized. Combined, our findings
raise the possibility that TSC2 subcellular localization is a general
mechanism for regulating this complex. It would be interesting
to study whether the other inputs known to regulate TSC2 also
affect its subcellular localization.EXPERIMENTAL PROCEDURES
Detailed experimental procedures are provided in the Extended Experimental
Procedures.
Immunoblot Quantifications
Immunoblots were imaged and quantified with a LI-COR Odyssey FC imaging
system, which has a larger dynamic range than what can be shown on the
figure images. Data analysis was performed on the raw data and not the image
displayed; hence, bands that look saturated on the figures for visualization
purposes do not impact the data analysis. Quantifications of coIP efficiency
(Figures 2C, 2D, and S2B) were calculated as the amount of Rag in the
FLAG-TSC2 IP minus the negative control IP, normalized to the amount of
TSC2 in the IP and the amount of Rag in the input.
Cell Imaging
All cell images within one panel were acquired and displayed with the same
settings. Details of confocal microscopy can be found in the Extended Exper-
imental Procedures.
Cell Culture
Drosophila S2 cells were cultured in Schneider’s medium and supplemented
with 10% FBS (PAA). HEK293FT cells (Invitrogen) and MEFs were cultured
in high-glucose Dulbecco’s modified Eagle’s medium (DMEM), supplemented
with 10% FBS (Biochrom), except PTEN/ MEFS, which were also supple-
mented with 2 mM Glutamine. TSC1/, TSC2+/+p53/, and TSC2/
p53/ MEFs were a kind gift by David Kwiatkowski and Michael Hall and
were described previously (Kwiatkowski et al., 2002; Zhang et al., 2003).
p14/ and EGFP-p14 reconstituted MEFs were a kind gift of Lukas Huber,
described in Teis et al. (2006). PTEN/ MEFs were provided by Hong Wu,
described in Lesche et al. (2002).798 Cell 156, 786–799, February 13, 2014 ª2014 Elsevier Inc.SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
seven figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cell.2014.01.024.
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